TY  - JOUR
T1  - Development of 3D Bioprinting Technology Using Modified Natural and Synthetic Hydrogels for Engineering Construction of Organs
A1  - S. I. Kubanov
A1  - S. V. Savina
A1  - C. V. Nuzhnaya
A1  - A. E. Mishvelov
A1  - M. B. Tsoroeva and et al
JF  - International Journal of Pharmaceutical And Phytopharmacological Research
JO  - Int J Pharm Phytopharmacol Res
SN  - 2250-1029
Y1  - 2019
VL  - 9
IS  - 5
SP  - 37
EP  - 42
N2  - The shortage of human organs for transplantation is one of the critical and unresolved problems in clinical medicine. An average of 18 people die every day in the world due to a shortage of donor organs. Regenerative medicine is an alternative to donor organs. The use of digital imaging technologies using CT and 3D bioprinter (bioprinting) is the so-called biomedical application of layered three-dimensional printing in order to solve the problem of obtaining copies of living organs. In the present article, we studied general bioprinting technologies and testing of chitosan-based bioplastics and hydrogels using 3D printing and different fillability (porosity) of the material for biocompatibility using stem cells. Also, the "DoctorCT" software was used for 3D printing of substrates of biocompatible plastics.
UR  - https://eijppr.com/article/development-of-3d-bioprinting-technology-using-modified-natural-and-synthetic-hydrogels-for-engineering-construction-of-organs
ER  -